6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Reward System Dysfunction
The brain's reward system plays a critical role in the development and maintenance of addictive behaviors. In individuals with addiction, the reward system may become dysregulated, leading to a heightened response to substances and a diminished ability to feel pleasure from non-addictive activities. Dysfunction in key areas, such as the nucleus accumbens and ventral tegmental area, can alter the release and processing of dopamine, reinforcing addictive behaviors. This dysregulation can create a vicious cycle where the individual continually seeks the substance or behavior to achieve the pleasurable feeling, even in the face of negative consequences. Treatment often involves therapies aimed at restoring balance within the reward system, such as cognitive-behavioral therapy, medication-assisted treatment, and mindfulness practices.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States